Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance.
暂无分享,去创建一个
Matthew R Cooperberg | Janet E Cowan | Kirsten L. Greene | M. Cooperberg | M. Meng | P. Carroll | K. Shinohara | S. Porten | J. Cowan | Peter R Carroll | Katsuto Shinohara | Sima P Porten | Jared M Whitson | Nannette Perez | Kirsten L Greene | Maxwell V Meng | J. Whitson | N. Perez | Nannette Perez
[1] J. Adolfsson,et al. Evaluation of tumor progression by repeated fine needle biopsies in prostate adenocarcinoma: modal deoxyribonucleic acid value and cytological differentiation. , 1990, The Journal of urology.
[2] A. Whittemore,et al. Low-grade, latent prostate cancer volume: predictor of clinical cancer incidence? , 1991, Journal of the National Cancer Institute.
[3] V. Pansadoro,et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy. , 2004, The Journal of urology.
[4] Jing Ma,et al. Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] M. Terris,et al. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. , 2006, Urology.
[6] Steven J. M. Jones,et al. A multi-institutional evaluation of active surveillance for low risk prostate cancer. , 2013, The Journal of urology.
[7] Laurence H Klotz,et al. Active surveillance with selective delayed intervention for favorable risk prostate cancer: clinical experience and a 'number needed to treat' analysis. , 2006, The Canadian journal of urology.
[8] B. Trock,et al. Risk stratification of men choosing surveillance for low risk prostate cancer. , 2009, The Journal of urology.
[9] Donald E Bailey,et al. Active surveillance for early‐stage prostate cancer , 2008, Cancer.
[10] A. Billis. Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails , 2009 .
[11] M. Cooperberg,et al. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. , 2009, Journal of the National Cancer Institute.
[12] G. Andriole. Active Surveillance for the Management of Prostate Cancer in a Contemporary Cohort: Dall'Era MA, Konety BR, Cowan JE, et al (Univ of California at San Francisco; et al) Cancer 112:2664-2670, 2008 § , 2012 .
[13] P. Walsh,et al. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. , 2002, The Journal of urology.
[14] J. Hanley,et al. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. , 1999, JAMA.
[15] J. Epstein,et al. Change in prostate cancer grade over time in men followed expectantly for stage T1c disease. , 2008, The Journal of urology.
[16] Kirsten L. Greene,et al. Surgical management after active surveillance for low‐risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment , 2011, BJU international.
[17] J. Epstein,et al. Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist. , 2001, Human pathology.
[18] James A Eastham,et al. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. , 2008, The Journal of urology.
[19] L. Klotz,et al. Active surveillance versus radical treatment for favorable-risk localized prostate cancer , 2006, Current treatment options in oncology.
[20] M. Cooperberg,et al. Active surveillance for the management of prostate cancer in a contemporary cohort , 2008, Cancer.
[21] J. Wheeler,et al. Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progression , 1993, Cancer.
[22] H. D. de Koning,et al. Gleason score, age and screening: Modeling dedifferentiation in prostate cancer , 2006, International journal of cancer.
[23] J. Brooks,et al. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. , 2007, Cancer research.
[24] P. Troncoso,et al. Radical prostatectomy findings in patients predicted to have low‐volume/low‐grade prostate cancer diagnosed by extended‐core biopsies: an analysis of volume and zonal distribution of tumour foci , 2009, BJU international.
[25] B. Trock,et al. Delayed versus immediate surgical intervention and prostate cancer outcome. , 2006, Journal of the National Cancer Institute.
[26] H. G. van der Poel,et al. Short‐term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study , 2010, BJU international.